BioVie Inc. (BIVI) Stock Price, News, Quote & History - Yahoo Finance

BioVie Inc. (BIVI) Stock Price, News, Quote & History - Yahoo Finance

BioVie's terlipressin liquid formulation patent approved in Japan, securing its place in the US, India, and Chile. The stable formulation benefits patients with cirrhosis and ascites, providing a significant advantage for home-care treatment.

Read More

Did you find this insightful?